CIK 0001636651 · Non-accelerated filer<br>Smaller reporting company
Ovid Therapeutics Inc.
Sign in to watch- Ticker
- OVID
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 465270895
- Phone
- 212-776-4381
- Business address
- 441 NINTH AVENUE, 14TH FLOOR, NEW YORK, NY, 10001
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale President and COO sold 5,279 shares at $0.56 ($2,956)
- 4 Open-market sale CBFO sold 3,902 shares at $0.56 ($2,185)
- 4 Derivatives Options or other derivatives
- 4 Grant or award CBFO acquired 43,750 shares (grant or award)
- 4 Grant or award President and COO acquired 43,750 shares (grant or award)
- 4 Open-market buy President and COO bought 6,810 shares at $0.73 ($4,971)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Open-market buy CEO bought 18,248 shares at $2.76 ($50,364)
- 4 Grant or award Chief Operating Officer acquired 28,125 shares (grant or award)
Page 2 of 10 · 182 filings